A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options. We live longer and longer, and as we age ...
FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...
We live longer and longer, and as we age, a lot of us develop a series of health issues and chronic diseases, including chronic obstructive pulmonary disease (COPD), which is found in around 600 ...
Verona Pharma is off to a promising start as it launches its first product, Ohtuvayre, a maintenance treatment for chronic obstructive pulmonary disorder (COPD). In 2024, Ohtuvayre generated sales of ...
A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. An ...
Grace Anne Dorney Koppel, wife of Ted, the longtime anchor of ABC News' Nightline, has been bringing more awareness to COPD, ...
AJMC®: What recent developments in the therapeutic landscape of chronic obstructive pulmonary disease (COPD) do you think have the greatest potential to shift how treatment is managed? Dr Martinez: ...
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according to ...
Hosted on MSN
FDA Greenlights Nucala as New Treatment for COPD
The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) that remains inadequately ...
Chronic obstructive pulmonary disease, or COPD, is a complex and progressive disease, and many patients continue to experience exacerbations, also known as flare-ups. For the past few decades, the ...
Belfast Live on MSN
'This breakthrough COPD treatment could make a real difference to patients like me'
Samuel Maclean, who has lived with the lung condition for several years, is among the first to benefit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results